References

  1. Mottet N, Avances C, Bastide C, Culine S, Ibora F, Kouri G et al. Penile tumors (Tumeurs du penis). Prog urol. 2004;14(4 Suppl 1):903, 905-11. PubMed | Google Scholar

  2. Cubilla AL, Lloveras B, Alemany L et al. Basaloid squamous cell carcinoma of the penis with papillary features: a clinicopathologic study of 12 cases. Am J Surg Pathol. 2012 Jun;36(6):869-75. PubMed | Google Scholar

  3. Chaux A, Netto GJ, Rodriguez IM et al. Epidemiologic profile, sexual history, pathologic features, and human papillomavirus status of 103 patients with penile carcinoma. World J Urol. 2013 Aug;31(4): 861-7. PubMed | Google Scholar

  4. Stankiewicz E, Kudahetti SC, Prowse DM, et al. HPV infection and immunochemical detection of cell- cycle markers in verrucous carcinoma of the penis. Mod Pathol. 2009 Sep;22(9):1160-8. PubMed | Google Scholar

  5. Muñoz N, Castelisague X, de Gonzalez AB, et al. HPV in the etiology of human cancer. Vaccine. 2006 Aug;24(Suppl 3):S3/1-10. PubMed | Google Scholar

  6. Yeok BB, Jussawalla DJ. Discriptiveepiderniologhy of the cancers of male genital organs in greater Bombay Indian J. Cancer. 1997 Mar;34(1):30-9. PubMed | Google Scholar

  7. Mangoha GA, Kaale RF. Epidennological and clinical aspects of carcinoma of penis at kenyatta national hospital. East African Mcd J. 1995 Jun;72(6):359-61. PubMed | Google Scholar

  8. Koifman L, Vides AJ, Koifman N et al. Epidemiological aspects of penile cancer in Rio de Janeiro: evaluation of 230 cases. IntBraz J Urol. 2011 Mar-Apr;37(2):231-40;discussion 240-3. PubMed | Google Scholar

  9. Daling JR, Madeleine MM, Johnson LG et al. Penile cancer: importance of circumcision, human papillomavirus and smoking in in situ and invasive disease. Int J Cancer. 2005 Sep;116(4):606-16. PubMed | Google Scholar

  10. Bertolotto M, Serafini G, Dogliotti L et al. Primary and secondary malignancies of the penis: ultrasound features. Abdom Imaging. 2005 Jan-Feb;30(1):108-12. PubMed | Google Scholar

  11. Kayes O, Minhas S, Allen C et al. The role of magnetic resonance imaging in the local staging of penile cancer. Eur Urol. 2007 May; 51(5):1313-8;discussion 1318-9. PubMed | Google Scholar

  12. Leijte JA, Kroon BK, Valdes Olmos RA, Nieweg OE, Horenblas S. Reliability and safety of current dynamic sentinel node biopsy for penile carcinoma. Eur Urol. 2007 Jul;52(1):170–7. PubMed | Google Scholar

  13. Hughes BE, Leijte JAP, Kroon BK, Shabbir MA, Swallow TW, Heenan SD et al. Lymph node metastasis in intermediate-risk penile squa- mous cell cancer: a two-centre experience. Eur Urol. 2010;57(4):688– 92. PubMed | Google Scholar

  14. Rigaud J, Avancès C, Camparo P, Durand X, Fléchon A, Murez T, Sèbe P, Coloby P, Culine S, Iborra F, Mottet N, Soulié M. Les membres du CCAFU: Recommandations en onco-urologie 2013 du CCAFU: tumeurs malignes du pénis. Prog Urol. 2013; 23(suppl 2):S135-S144. PubMed | Google Scholar

  15. Koifman L, Hampl D, Koifman N et al. Radical open inguinal lymphadenectomy for penile carcinoma: surgical technique, early complications and late outcomes. J Urol. 2013 Dec;190(6):2086-92. PubMed | Google Scholar

  16. Lughezzani G, Catanzaro M, Torelli T et al. The relationship between lymph node ratio and cancer- specific survival in a contemporary series of patients with penile cancer and lymph node metastases. BJU Int. 2013 Oct15. PubMed | Google Scholar

  17. Catalona WJ. Modified inguinal lymphadenectomy for carcinoma of the penis with preservation of saphenous veins: Technique and preliminary results. J Urol. 1988 Aug;140(2):306–10. PubMed | Google Scholar

  18. Bouchot O, Rigaud J, Maillet F, Hetet JF, KaramG. Morbidity of inguinal lymphadenectomy for invasive penile carcinoma. Eur Urol. 2004 Jun;45(6):761–5, discussion 765-6. PubMed | Google Scholar

  19. Leijte JAP, Kirrander P, Antonini N et al. Recurrence patterns of squamous cell carcinoma of the penis: recommendations for follow-up based on a two-centre analysis of 700 patients. Eur Urol. 2008 Jul;54(1):161-8. PubMed | Google Scholar